Skip to main content

I Can’t Stop the Hemolysis!

  • Chapter
  • First Online:
  • 753 Accesses

Abstract

A 27-year-old woman with a history of sickle cell disease is admitted with pain crisis (pain in extremities and back) and possible sepsis. The patient, who has a history of anti-Fya and anti-S alloantibodies, has had several admissions to the hospital for pain crisis over the past 5 years. She was transfused two units of red blood cells (RBCs) 1 year ago and received RBC exchange transfusion (six units) for acute chest syndrome 2 years ago; all RBCs were matched by extended phenotype (C-, E-, K-negative) as per the blood bank’s policy for sickle cell patients. A type and screen sample (ethylenediaminetetraacetic acid, EDTA anticoagulant) is submitted to the blood bank.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37(4):382–92.

    Article  CAS  Google Scholar 

  2. Win N, Sinha S, Lee E, Mills W. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Transfus Med Rev. 2010;24(1):64–7.

    Article  Google Scholar 

  3. Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion. 2015;55(3):623–8.

    Article  CAS  Google Scholar 

  4. Bachmeyer C, Maury J, Parrot A, Bachir D, Stankovic K, Girot R. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol. 2010;85(1):91–2.

    PubMed  Google Scholar 

  5. Uhlmann EJ, Shenoy S, Goodnough L. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion. 2013;54:384–8.

    PubMed  Google Scholar 

  6. Gouveia ME, Soares NB, Santoro MS, de Azevedo FCM. Hyperhemolysis syndrome in a patient with sickle cell anemia: case report. Rev Bras Hematol Hemoter. 2015;37(4):266–8.

    Article  Google Scholar 

  7. Eberly LA, Osman D, Collins NP. Hyperhemolysis syndrome without underlying hematologic disease. Case Rep Hematol. 2015;2015:180526, 3 p.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Friedman, M.T., West, K.A., Bizargity, P., Annen, K., Jhang, J.S. (2018). I Can’t Stop the Hemolysis!. In: Immunohematology and Transfusion Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-90960-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90960-8_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90959-2

  • Online ISBN: 978-3-319-90960-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics